mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.03 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |